Skip to main navigation Skip to search Skip to main content

Metabolic imaging with hyperpolarized [1-13C] pyruvate in patient-derived preclinical mouse models of breast cancer

  • Susana Ros*
  • , Alan J. Wright
  • , Alejandra Bruna
  • , Carlos Caldas
  • , Kevin M. Brindle*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

13C nuclear spin hyperpolarization can increase the sensitivity of detection in an MRI experiment by more than 10,000-fold. 13C magnetic resonance spectroscopic imaging (MRSI) of hyperpolarized 13C label exchange between injected [1-13C]pyruvate and the endogenous tumor lactate pool can be used clinically to assess tumor grade and response to treatment. We describe here an experimental protocol for using this technique in patient-derived and established cell line xenograft models of breast cancer in the mouse. For complete details on the use and execution of this protocol, please refer to Ros et al. (2020).

Original languageEnglish
Article number100608
JournalSTAR Protocols
Volume2
Issue number3
DOIs
StatePublished - 17 Sep 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2021 The Authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biophysics
  • Cancer
  • Metabolism
  • Model Organisms

Fingerprint

Dive into the research topics of 'Metabolic imaging with hyperpolarized [1-13C] pyruvate in patient-derived preclinical mouse models of breast cancer'. Together they form a unique fingerprint.

Cite this